Pulmonx(LUNG)
$2.98+0.18 (+6.43%)
LUNG
Pulmonx financials statements
$2.98
At close:+0.18 (+6.43%)
Want to see LUNG full AI Analyst Report?
Pulmonx (LUNG) Ratios
154 Followers
Pulmonx Ratios
LUNG's free cash flow for Q3 2026 was $-3.19M. For the 2026 fiscal year, LUNG's free cash flow was decreased by $-8.00K and operating cash flow was $-3.18M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.07 | 5.58 | 6.50 | 9.14 | 11.85 |
| Quick Ratio | 4.28 | 4.88 | 5.77 | 8.35 | 10.92 |
| Cash Ratio | 3.49 | 2.90 | 3.61 | 5.50 | 8.46 |
| Solvency Ratio | -0.70 | -0.71 | -0.99 | -1.45 | -1.14 |
| Operating Cash Flow Ratio | -1.62 | -1.29 | -1.62 | -2.44 | -2.36 |
| Short-Term Operating Cash Flow Coverage | -24.66 | -9.93 | -17.45 | -501.51 | -455.26 |
| Net Current Asset Value | $ 26.51M | $ 59.21M | $ 90.96M | $ 129.28M | $ 166.07M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.44 | 0.35 | 0.23 | 0.13 | 0.11 |
| Debt-to-Equity Ratio | 1.04 | 0.66 | 0.35 | 0.16 | 0.14 |
| Debt-to-Capital Ratio | 0.51 | 0.40 | 0.26 | 0.14 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.41 | 0.28 | 0.23 | 0.10 | 0.08 |
| Financial Leverage Ratio | 2.39 | 1.90 | 1.50 | 1.26 | 1.22 |
| Debt Service Coverage Ratio | -11.14 | -7.68 | -10.33 | -48.74 | -51.05 |
| Interest Coverage Ratio | -17.01 | -16.45 | -19.16 | -55.01 | -57.06 |
| Debt to Market Cap | 0.43 | 0.14 | 0.08 | 0.06 | 0.02 |
| Interest Debt Per Share | 1.46 | 1.53 | 1.18 | 0.69 | 0.76 |
| Net Debt to EBITDA | 0.28 | 0.28 | 0.76 | 1.38 | 2.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 74.19% | 74.00% | 73.90% | 74.29% | 73.59% |
| EBIT Margin | -55.50% | -62.52% | -83.06% | -107.16% | -98.09% |
| EBITDA Margin | -54.33% | -60.62% | -80.22% | -104.34% | -96.29% |
| Operating Profit Margin | -59.30% | -68.87% | -90.19% | -109.27% | -97.70% |
| Pretax Profit Margin | -58.98% | -66.71% | -87.76% | -109.15% | -99.80% |
| Net Profit Margin | -59.67% | -67.30% | -88.60% | -109.80% | -100.51% |
| Continuous Operations Profit Margin | -59.67% | -67.30% | -88.60% | -109.80% | -100.51% |
| Net Income Per EBT | 101.17% | 100.89% | 100.95% | 100.60% | 100.71% |
| EBT Per EBIT | 99.47% | 96.86% | 97.31% | 99.89% | 102.14% |
| Return on Assets (ROA) | -41.77% | -34.63% | -34.22% | -30.42% | -20.69% |
| Return on Equity (ROE) | -99.79% | -65.72% | -51.42% | -38.26% | -25.18% |
| Return on Capital Employed (ROCE) | -49.13% | -41.69% | -40.06% | -33.47% | -21.74% |
| Return on Invested Capital (ROIC) | -48.54% | -40.53% | -38.74% | -32.85% | -21.51% |
| Return on Tangible Assets | -42.77% | -35.13% | -34.68% | -30.82% | -20.92% |
| Earnings Yield | -60.06% | -21.24% | -12.57% | -18.84% | -4.20% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.50 | 6.08 | 5.27 | 5.78 | 6.99 |
| Payables Turnover | 5.98 | 5.69 | 11.97 | 7.85 | 8.08 |
| Inventory Turnover | 1.47 | 1.29 | 1.07 | 0.95 | 0.79 |
| Fixed Asset Turnover | 4.47 | 3.91 | 9.24 | 5.11 | 3.76 |
| Asset Turnover | 0.70 | 0.51 | 0.39 | 0.28 | 0.21 |
| Working Capital Turnover Ratio | 0.94 | 0.70 | 0.49 | 0.31 | 0.23 |
| Cash Conversion Cycle | 235.27 | 279.33 | 379.68 | 401.90 | 471.92 |
| Days of Sales Outstanding | 48.69 | 60.08 | 69.20 | 63.11 | 52.20 |
| Days of Inventory Outstanding | 247.60 | 283.37 | 340.97 | 385.29 | 464.89 |
| Days of Payables Outstanding | 61.02 | 64.11 | 30.49 | 46.51 | 45.16 |
| Operating Cycle | 296.29 | 343.44 | 410.17 | 448.41 | 517.08 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.80 | -0.81 | -0.99 | -1.22 | -1.15 |
| Free Cash Flow Per Share | -0.81 | -0.84 | -1.01 | -1.25 | -1.25 |
| Dividend Paid and CapEx Coverage Ratio | -71.78 | -21.79 | -46.60 | -34.25 | -11.29 |
| Capital Expenditure Coverage Ratio | -71.78 | -21.79 | -46.60 | -34.25 | -11.29 |
| Operating Cash Flow Coverage Ratio | -0.58 | -0.56 | -0.91 | -1.85 | -1.57 |
| Operating Cash Flow to Sales Ratio | -0.36 | -0.38 | -0.55 | -0.84 | -0.86 |
| Free Cash Flow Yield | -36.59% | -12.42% | -7.93% | -14.85% | -3.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.66 | -4.72 | -7.96 | -5.31 | -23.81 |
| Price-to-Sales (P/S) Ratio | 0.99 | 3.17 | 7.05 | 5.83 | 23.93 |
| Price-to-Book (P/B) Ratio | 1.66 | 3.09 | 4.09 | 2.03 | 6.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.73 | -8.05 | -12.60 | -6.73 | -25.69 |
| Price-to-Operating Cash Flow Ratio | -2.77 | -8.42 | -12.87 | -6.93 | -27.97 |
| Price-to-Earnings Growth (PEG) Ratio | 0.22 | 0.47 | -12.65 | -0.30 | -0.48 |
| Enterprise Value Multiple | -1.55 | -4.94 | -8.02 | -4.20 | -22.24 |
| Enterprise Value | 76.27M | 251.13M | 442.05M | 235.39M | 1.04B |
| EV to EBITDA | -1.55 | -4.94 | -8.02 | -4.20 | -22.24 |
| EV to Sales | 0.84 | 3.00 | 6.44 | 4.39 | 21.41 |
| EV to Free Cash Flow | -2.32 | -7.61 | -11.51 | -5.07 | -22.99 |
| EV to Operating Cash Flow | -2.35 | -7.96 | -11.75 | -5.22 | -25.02 |
| Tangible Book Value Per Share | 1.26 | 2.13 | 3.05 | 4.08 | 5.28 |
| Shareholders’ Equity Per Share | 1.33 | 2.19 | 3.12 | 4.15 | 5.35 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Revenue Per Share | 2.22 | 2.14 | 1.81 | 1.45 | 1.34 |
| Net Income Per Share | -1.33 | -1.44 | -1.60 | -1.59 | -1.35 |
| Tax Burden | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
| Interest Burden | 1.06 | 1.07 | 1.06 | 1.02 | 1.02 |
| Research & Development to Revenue | 0.22 | 0.21 | 0.26 | 0.29 | 0.27 |
| SG&A to Revenue | 1.12 | 1.22 | 1.31 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.27 | 0.32 | 0.00 | 0.00 |
| Income Quality | 0.60 | 0.56 | 0.62 | 0.77 | 0.85 |
Currency in USD
